Shuttle Pharmaceuticals Holdings (SHPH) Return on Capital Employed (2022 - 2026)

Shuttle Pharmaceuticals Holdings' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 394.16% for Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 4151.0% year-over-year to 394.16% in Q1 2026; TTM through Mar 2026 was 394.16%, a 4151.0% increase from a year earlier, with the FY2025 full-year figure at 807.51%, up 109305.0% from the prior year.
• Return on Capital Employed fell to 394.16% in Q1 2026 per SHPH's latest filing, from 1244.66% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 1244.66% in Q4 2025 and bottomed at 13704.01% in Q4 2024.
• The 5-year median for Return on Capital Employed is 194.02% (2024), against an average of 1662.76%.
• Across the five-year window, Return on Capital Employed slumped 1359919 bps in 2024 and surged 1494866 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 29.14% in 2022, then plunged by 260 bps to 104.82% in 2023, then plunged by 12974 bps to 13704.01% in 2024, then soared by 109 bps to 1244.66% in 2025, then tumbled by 132 bps to 394.16% in 2026.
• Per Business Quant, the three latest SHPH Return on Capital Employed figures stand at 394.16% (Q1 2026), 1244.66% (Q4 2025), and 426.21% (Q3 2025).